annual total liabilities:
$309.95M-$36.81M(-10.62%)Summary
- As of today (June 28, 2025), CRSP annual total liabilities is $309.95 million, with the most recent change of -$36.81 million (-10.62%) on December 31, 2024.
- During the last 3 years, CRSP annual total liabilities has fallen by -$42.46 million (-12.05%).
- CRSP annual total liabilities is now -15.68% below its all-time high of $367.58 million, reached on December 31, 2022.
Performance
CRSP Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$336.94M+$26.99M(+8.71%)Summary
- As of today (June 28, 2025), CRSP quarterly total liabilities is $336.94 million, with the most recent change of +$26.99 million (+8.71%) on March 31, 2025.
- Over the past year, CRSP quarterly total liabilities has dropped by -$18.14 million (-5.11%).
- CRSP quarterly total liabilities is now -15.64% below its all-time high of $399.40 million, reached on September 30, 2022.
Performance
CRSP quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CRSP Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | -5.1% |
| 3 y3 years | -12.1% | -6.7% |
| 5 y5 years | +143.4% | +178.0% |
CRSP Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.7% | at low | -15.6% | +8.7% |
| 5 y | 5-year | -15.7% | +143.4% | -15.6% | +178.0% |
| alltime | all time | -15.7% | +3546.1% | -15.6% | +303.5% |
CRSP Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $336.94M(+8.7%) |
| Dec 2024 | $309.95M(-10.6%) | $309.95M(-2.1%) |
| Sep 2024 | - | $316.47M(-11.8%) |
| Jun 2024 | - | $358.90M(+1.1%) |
| Mar 2024 | - | $355.08M(+2.4%) |
| Dec 2023 | $346.77M(-5.7%) | $346.77M(-3.4%) |
| Sep 2023 | - | $359.04M(-5.8%) |
| Jun 2023 | - | $380.99M(-2.2%) |
| Mar 2023 | - | $389.47M(+6.0%) |
| Dec 2022 | $367.58M(+4.3%) | $367.58M(-8.0%) |
| Sep 2022 | - | $399.40M(+7.2%) |
| Jun 2022 | - | $372.53M(+3.1%) |
| Mar 2022 | - | $361.26M(+2.5%) |
| Dec 2021 | $352.42M(+115.2%) | $352.42M(+14.1%) |
| Sep 2021 | - | $308.80M(+4.4%) |
| Jun 2021 | - | $295.72M(+94.0%) |
| Mar 2021 | - | $152.41M(-6.9%) |
| Dec 2020 | $163.73M | $163.73M(+15.5%) |
| Sep 2020 | - | $141.72M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $135.86M(+12.1%) |
| Mar 2020 | - | $121.20M(-4.8%) |
| Dec 2019 | $127.33M(+31.5%) | $127.33M(-1.1%) |
| Sep 2019 | - | $128.71M(+1.7%) |
| Jun 2019 | - | $126.56M(+7.2%) |
| Mar 2019 | - | $118.06M(+21.9%) |
| Dec 2018 | $96.82M(+15.9%) | $96.82M(-4.7%) |
| Sep 2018 | - | $101.59M(+15.5%) |
| Jun 2018 | - | $87.98M(+4.6%) |
| Mar 2018 | - | $84.12M(+0.7%) |
| Dec 2017 | $83.51M(-25.5%) | $83.51M(-19.2%) |
| Sep 2017 | - | $103.36M(-3.6%) |
| Jun 2017 | - | $107.17M(+0.0%) |
| Mar 2017 | - | $107.17M(-4.4%) |
| Dec 2016 | $112.12M(-40.5%) | $112.12M(-67.1%) |
| Sep 2016 | - | $341.19M(+116.3%) |
| Jun 2016 | - | $157.72M(-16.4%) |
| Dec 2015 | $188.55M(+2117.9%) | $188.55M |
| Dec 2014 | $8.50M | - |
FAQ
- What is CRISPR Therapeutics AG annual total liabilities?
- What is the all time high annual total liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual total liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total liabilities?
- What is the all time high quarterly total liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly total liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total liabilities?
The current annual total liabilities of CRSP is $309.95M
What is the all time high annual total liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total liabilities is $367.58M
What is CRISPR Therapeutics AG annual total liabilities year-on-year change?
Over the past year, CRSP annual total liabilities has changed by -$36.81M (-10.62%)
What is CRISPR Therapeutics AG quarterly total liabilities?
The current quarterly total liabilities of CRSP is $336.94M
What is the all time high quarterly total liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total liabilities is $399.40M
What is CRISPR Therapeutics AG quarterly total liabilities year-on-year change?
Over the past year, CRSP quarterly total liabilities has changed by -$18.14M (-5.11%)